S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in

USANA Health Sciences Earnings Date, Estimates & History

+0.94 (+1.01 %)
(As of 02/24/2021 12:00 AM ET)
Today's Range
Now: $93.78
50-Day Range
MA: $85.53
52-Week Range
Now: $93.78
Volume156,851 shs
Average Volume105,251 shs
Market Capitalization$1.97 billion
P/E Ratio17.37
Dividend YieldN/A


USANA Health Sciences (NYSE:USNA) Earnings Information

USANA Health Sciences last announced its earnings data on February 8th, 2021. The reported $1.87 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.48. The business had revenue of $310.50 million for the quarter, compared to the consensus estimate of $286.71 million. Its revenue was up 14.4% compared to the same quarter last year. USANA Health Sciences has generated $4.41 earnings per share over the last year and currently has a price-to-earnings ratio of 17.4. USANA Health Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 20th, 2021 based off prior year's report dates.

USANA Health Sciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

USANA Health Sciences (NYSE:USNA) Earnings Estimates

2021 EPS Consensus Estimate: $6.23
2022 EPS Consensus Estimate: $6.36
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211$1.58$1.58$1.58
Q2 20211$1.64$1.64$1.64
Q3 20211$1.55$1.55$1.55
Q4 20211$1.46$1.46$1.46
Q1 20221$1.56$1.56$1.56
Q2 20221$1.65$1.65$1.65
Q3 20221$1.59$1.59$1.59
Q4 20221$1.56$1.56$1.56

USANA Health Sciences (NYSE USNA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/8/202112/31/2020$1.39$1.87$1.87$286.71 million$310.50 millionTranscript
10/20/20209/30/2020$1.29$1.44$1.44$281.80 million$298.50 millionTranscript
7/21/20206/30/2020$1.08$1.32$1.32$267.80 million$258.99 millionTranscript
4/21/20203/31/2020$0.57$1.23$1.23$220.40 million$266.62 millionTranscript
2/4/2020Q4 2019$0.98$1.41$1.41$256.46 million$271.30 millionTranscript
10/22/2019Q3 2019$0.87$1.09$1.09$256.22 million$260.60 millionTranscript
7/23/2019Q2$0.93$0.91$0.91$254.66 million$256.00 millionListen
4/30/20193/31/2019$0.99$1.01$1.01$272.20 million$272.90 millionListen
2/5/201912/31/2018$1.33$1.32$1.32$305.79 million$299.02 millionN/A
10/23/20189/30/2018$1.10$1.24$1.24$289.54 million$296.80 millionN/A
7/24/2018Q2 2018$1.11$1.36$1.36$278.41 million$301.50 millionN/A
4/24/2018Q1 2018$1.05$1.19$1.19$268.93 million$292.00 millionN/A
2/6/2018Q4 2017$1.00$1.11$2.46$258.67 million$273.11 millionN/A
10/24/2017Q3 2017$0.91$1.02$1.07$259.52 million$261.77 millionN/A
7/25/2017Q2 2017$1.06$0.98$1.03$273.61 million$257.10 millionN/A
5/2/2017Q1 2017$0.92$0.91$0.96$255.32 millionListen
2/7/2017Q4 2016$0.90$0.87$0.87$253.52 million$252.90 millionListen
10/25/2016Q3 2016$1.06$1.20$1.20$263.37 million$254.22 millionListen
7/26/2016Q2 2016$0.97$1.04$1.04$256.66 million$258.50 millionListen
5/3/2016Q1 2016$0.93$0.75$0.75$244.05 million$240.45 millionListen
2/9/2016Q4 2015$0.95$0.92$0.92$250.82 million$232.60 millionListen
11/3/2015Q3 2015$0.91$0.96$0.96$230.79 million$233.30 millionListen
8/4/2015Q2 2015$0.86$0.96$0.96$211.86 million$233.20 millionListen
5/5/2015Q1 2015$0.75$0.75$198.21 million$219.40 millionListen
2/10/2015Q4 2014$0.83$0.83$219.10 million$227.90 millionListen
10/28/2014Q3 2014$0.74$0.74$190.50 million$191.90 millionListen
7/29/2014Q2 2014$0.74$0.68$0.68$198.30 million$188.30 millionListen
4/29/2014Q1 2014$0.66$0.58$0.58$185.85 million$182.40 millionListen
2/4/2014Q4 2013$0.63$0.71$0.71$175.53 million$186.30 millionListen
10/22/2013Q3 2013$0.57$0.58$0.58$172.40 million$173.70 millionListen
7/23/2013Q2 2013$0.65$0.86$0.86$176.60 million$189.10 millionListen
4/23/2013Q1 2013$0.56$0.64$0.64$171.77 million$169.10 millionListen
2/5/2013Q4 2012$1.21$1.27$165.80 million$168.50 millionListen
4/24/2012Q1 2012$0.35$0.45$0.45N/A
7/26/2011Q2 2011$0.40$0.44$0.44N/A
10/26/2010Q3 2010$0.32$0.40$0.40N/A
7/27/2010Q2 2010$0.31$0.34$0.34N/A
4/27/2010Q1 2010$0.25$0.31$0.31N/A
2/9/2010Q4 2009$0.30$0.33$0.33N/A
10/27/2009Q3 2009$0.25$0.25$0.25N/A
7/28/2009Q2 2009$0.23$0.29$0.29N/A
4/28/2009Q1 2009$0.20$0.22$0.22N/A
2/23/2009Q4 2008$0.28$0.28$0.42N/A
10/14/2008Q3 2008$0.30$0.25$0.25N/A
7/22/2008Q2 2008$0.31$0.31$0.31N/A
4/21/2008Q1 2008$0.23$0.23$0.23N/A
2/5/2008Q4 2007$0.34$0.33$0.33N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.